Clinical Trial Update: BP101 for Adults With Female Sexual Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for BP101 in adults with hypoactive sexual desire disorder and female sexual dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Dysfunction
• Hypoactive Sexual Desire Disorder

Drugs mentioned

• BP101 (BP101)

Snippet

Sponsor: Ivix LLX | Conditions: Hypoactive Sexual Desire Disorder, Female Sexual Dysfunction | Phase 3 | Status: COMPLETED